Bruker Launches Molecular Phenomics Research Tool for Long COVID Multi-Organ Risk Assessment
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read MorePosted by Andy Lundin | Oct 27, 2022 | Covid 19, Research |
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read MorePosted by Chris Wolski | Oct 7, 2022 | Quality Control Programs |
Multiple instruments as the core of testing provides a number of advantages and complexities for clinical laboratories.
Read MorePosted by Andy Lundin | Sep 23, 2022 | Covid 19, Diabetes & Metabolic Diseases |
Children who were infected with COVID show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study.
Read MorePosted by Andy Lundin | Sep 21, 2022 | Diagnostic Technologies |
Allelica announced that ancestry-specific polygenic risk score analysis is now available as a LDT for healthcare providers.
Read MorePosted by Chris Wolski | Sep 15, 2022 | Covid 19 |
As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests.
Read More